Skip to main content
SpringerLink
Log in

Prognostic Significance of Pathologic Features of Ovarian Carcinoma

  • Chapter
Book cover Ovarian Pathology

Part of the book series: Current Topics in Pathology ((CT PATHOLOGY,volume 78))

Abstract

The subject of the relationship of histologic features to prognosis and treatment in ovarian cancer is obviously a broad one, considering the many histologic types of ovarian that exist, not to mention the rapidly changing therapeutic strategies that have evolved within the past decade. Since the great majority of primary malignant tumors of the ovary are of “common epithelial” type (those thought to arise ultimately from the mesothelium covering the ovarian surface) — over 90% in the population-based series of Katsube et al. (1982) — my comments in this chapter will be confined to this group of tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • August CZ, Murad TM, Newton M (1985) Multiple focal extraovarian serous carcinoma. Int J Gynecol Pathol 4: 11–23.

    Article  PubMed  CAS  Google Scholar 

  • Austin RM, Norris HJ (1987) Malignant Brenner tumor and transitional cell carcinoma of the ovary: A comparison. Int J Gynecol Pathol 6: 29–39.

    Article  PubMed  CAS  Google Scholar 

  • Baak JPA, Delemarre JFM, Langley FA, Talerman A (1986a) Grading ovarian tumors: Evaluation of decision making by different pathologists. Anal Quant Cytol Histol 8: 349–353.

    PubMed  CAS  Google Scholar 

  • Baak JPA, Langley FA, Talerman A, Delamarre JFM (1986 b) Interpathologist disagreement in ovarian tumor grading and typing. Anal Quant Cytol Histol 8: 354–357.

    PubMed  CAS  Google Scholar 

  • Baak JPA, Lindeman J, Overdiep SH, Langley FA (1982) Disagreement of histopathological diagnoses of different pathologists in ovarian tumours — with some theoretical considerations. Eur J Obstet Gynecol Reprod Biol 13: 51–55.

    Article  PubMed  CAS  Google Scholar 

  • Barber HRK, Sommers SC, Snyder R, Kwon TH (1975) Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer. Am J Obstet Gynecol 121: 795–807.

    PubMed  CAS  Google Scholar 

  • Björkholm E, Pettersson F, Einhorn N et al. (1982) Long-term follow-up and prognostic factors in ovarian carcinoma: The Radiumhemmet series 1958 to 1973. Acta Radiol Oncol 21 Fasc 6: 413–419.

    Article  Google Scholar 

  • Broders AC (1926) Carcinoma: Grading and practical application. Arch Pathol 2: 376–380.

    Google Scholar 

  • Bruckner HW, Cohen CJ, Goldberg JD et al. (1983) Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer. Am J Obstet Gynecol 145: 653–658.

    PubMed  CAS  Google Scholar 

  • Bruckner HW, Dinse GE, Davis TE et al. (1985) A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer. Cancer 55: 26–40.

    Article  PubMed  CAS  Google Scholar 

  • Cain JM, Saigo PE, Pierce VK, et al. (1986) A review of second-look laparotomy for ovarian cancer. Gynecol Oncol 23: 14–25.

    Article  PubMed  CAS  Google Scholar 

  • Chen SS, Lee L (1984) Prognostic significance of morphology of tumor and retroperitoneal lymph nodes in epithelial carcinoma of the ovary. Gynecol Oncol 18: 87–93.

    Article  PubMed  CAS  Google Scholar 

  • Coffin CM, Adcock LL, Dehner LP (1985) The second-look operation for ovarian neoplasms: A study of 85 cases emphasizing cytologic and histologic problems. Int J Gynecol Pathol 4: 97–109.

    Article  PubMed  CAS  Google Scholar 

  • Cohen CJ, Goldberg JD, Holland JF et al. (1983) Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol 145: 955–967.

    PubMed  CAS  Google Scholar 

  • Conte PF, Bruzzone M, Chiara S et al. (1986) A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. J Clin Oncol 4: 965–971.

    PubMed  CAS  Google Scholar 

  • Day TG Jr, Gallager HS, Rutledge FN (1975) Epithelial carcinoma of the ovary: Prognostic importance of histologic grade. Cancer Inst Monogr 42: 15–18.

    Google Scholar 

  • Decker DG, Malkasian GD Jr, Taylor WF (1975) Prognostic importance of histologic grading in ovarian carcinoma. Nat Cancer Inst Monogr 42: 9–11.

    PubMed  CAS  Google Scholar 

  • Dembo AJ, Bush RS (1982) Current concepts in cancer: Ovary — Treatment for Stages III and IV: Choice of postoperative therapy based on prognostic factors. Int J Rad Oncol Biol Phys 8: 893–897.

    CAS  Google Scholar 

  • Demopoulos RI, Bigelow B, Blaustein A et al. (1984) Characterization and survival of patients with serous cystadenocarcinoma of the ovaries. Obstet Gynecol 64: 557–563.

    PubMed  CAS  Google Scholar 

  • Edmonson JH, McCormack GW, Fleming TR et al. (1985) Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for Stage III and IV ovarian carcinomas. Cancer Treat Rep 69: 1243–1248.

    PubMed  CAS  Google Scholar 

  • Edwards CL, Herson J, Gershenson DM et al. (1983) A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, Adriamycin, and cyclophosphamide in advanced ovarian cancer. Gynecol Oncol 15: 261–277.

    Article  PubMed  CAS  Google Scholar 

  • Eifel P, Hendrickson M, Ross J et al. (1982) Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 50: 163–170.

    Article  PubMed  CAS  Google Scholar 

  • Einhorn N, Nilsson BO, Sjovall K (1985) Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population. Cancer 55: 2019–2025.

    Article  PubMed  CAS  Google Scholar 

  • Erhardt K, Auer G, Bjorkholm E et al. (1984) Prognostic significance of nuclear DNA content in serous ovarian tumors. Cancer Res 44: 2198–2202.

    PubMed  CAS  Google Scholar 

  • Farhi DC, Silverberg SG (1982) Pseudometastases in female genital cancer. Pathol Annu 17(1): 47–76.

    PubMed  Google Scholar 

  • Friedlander ML, Hedley DW, Taylor IW et al. (1984) Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 44: 397–400.

    PubMed  CAS  Google Scholar 

  • Gershenson DM, Copeland LJ, Wharton JT et al. (1985) Prognosis of surgically determined complete responders in advanced ovarian cancer. Cancer 55: 1129–1135.

    Article  PubMed  CAS  Google Scholar 

  • Guthrie D, Davy MLJ, Philips PR (1984) A study of 656 patients with “early” ovarian cancer. Gynecol Oncol 17: 363–369.

    Article  PubMed  CAS  Google Scholar 

  • Hernandez E, Bhagavan BS, Parmley TH, Rosenshein NB (1984) Interobserver variability in the interpretation of epithelial ovarian cancer. Gynecol Oncol 17: 117–123.

    Article  PubMed  CAS  Google Scholar 

  • Iverson OE, Skaarland E, Utaaker E (1986) Steroid receptor content in human tumors: Survival of patients with ovarian carcinoma related to steroid receptor content. Gynecol Oncol 23: 65–76.

    Article  Google Scholar 

  • Jacobs AJ, Deligdish L, Deppe G, Cohen CJ (1982) Histologic correlates of virulence in ovarian adenocarcinoma. I. Effects of differentiation. Am J Obstet Gynecol 143: 574–580.

    PubMed  CAS  Google Scholar 

  • Katsube Y, Berg JW, Silverberg SG (1982) Epidemiologic pathology of ovarian tumors: A histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Area, 1 July–31 December 1969 and 1 July–31 December 1979. Int J Gynecol Pathol 1: 3–16.

    Article  PubMed  CAS  Google Scholar 

  • Klein B, Falkson G, Smit CF (1985) Advanced ovarian carcinoma: Factors influencing survival. Cancer 55: 1829–1834.

    Article  PubMed  CAS  Google Scholar 

  • Malkasian GD Jr, Melton LJ III, O’Brien PC, Greene MH (1984) Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Obstet Gynecol 149: 274–284.

    PubMed  Google Scholar 

  • McCaughey WTE, Kirk ME, Lester W, Dardick I (1984) Peritoneal epithelial lesions associated with proliferative serous tumors of ovary. Histopathology 8: 195–208.

    Article  PubMed  CAS  Google Scholar 

  • Miller DS, Ballon SC, Teng NNH et al. (1986) A critical reassessment of second-look laparotomy in epithelial ovarian carcinoma. Cancer 57: 530–535.

    Article  PubMed  CAS  Google Scholar 

  • Neijt JP, ten Bokkel Huinink WW, van der Burgmel et al. (1984) Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma. Lancet 2: 594–600.

    Article  PubMed  CAS  Google Scholar 

  • Ozols RF, Garvin AJ, Costa J et al. (1979) Histologic grade in advance ovarian cancer. Cancer Treat Rep 63: 255–263.

    PubMed  CAS  Google Scholar 

  • Ozols RF, Garvin AJ, Costa J et al. (1980) Advanced ovarian cancer: Correlation of histologic grade with response to therapy and survival. Cancer 45: 572–581.

    Article  PubMed  CAS  Google Scholar 

  • Podratz KC, Malkasian GD Jr, Hilton JF et al. (1985) Second-look laparotomy in ovarian cancer: Evaluation of pathologic variables. Am J Obstet Gynecol 152: 230–238.

    PubMed  CAS  Google Scholar 

  • Schray M, Martinez A, Cox R, Ballon S (1983) Radiotherapy in epithelial ovarian cancer: Analysis of prognostic factor based on long-term experience. Obstet Gynecol 62: 373–382.

    Article  PubMed  CAS  Google Scholar 

  • Scully RE (1975 a) World Health Organization Classification and Nomenclature of Ovarian Cancer. Nat Cancer Monogr 42: 5–7.

    CAS  Google Scholar 

  • Scully RE (1975b) Discussion. Nat Cancer Inst Monogr 42: 19–21.

    Google Scholar 

  • Serov SF, Scully RE, Sobin LH (1973) International Histological Classification of Tumours. No. 9, Histological Typing of Ovarian Tumours. Geneva, World Health Organization.

    Google Scholar 

  • Sidawy MS, Silverberg SG (1987) Endosalpingiosis in female peritoneal washings. A diagnostic pitfall. Int J Gynecol Pathol 6: 340–346.

    Article  PubMed  CAS  Google Scholar 

  • Sigurdsson K, Alm P, Gullberg B (1983) Prognostic factors in malignant epithelial ovarian tumors. Gynecol Oncol 15: 370–380.

    Article  PubMed  CAS  Google Scholar 

  • Smirz LR, Stehman FB, Ulbright TM et al. (1985) Second-look laporatomy after chemotherapy in the management of ovarian malignancy. Am J Obstet Gynecol 152: 661–668.

    PubMed  CAS  Google Scholar 

  • Sneige N, Fernandez T, Copeland LJ, Katz RL (1986) Müllerian inclusions in peritoneal washings: Potential source of error in cytologic diagnosis. Acta Cytol 30: 271–276.

    PubMed  CAS  Google Scholar 

  • Sorbe B, Frankendal BO, Veress B (1982) Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 59: 576–582.

    PubMed  CAS  Google Scholar 

  • Swenerton KD, Hislop TG, Spinelli J et al. (1985) Ovarian carcinoma: A multivariate analysis of prognostic factors. Obstet Gynecol 65: 264–270.

    PubMed  CAS  Google Scholar 

  • Tobacman JK, Tucker MA, Kase R et al. (1982) Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian — cancer — prone families. Lancet 2: 795.

    Article  PubMed  CAS  Google Scholar 

  • Volm M, Brüggermann A, Günther M et al. (1985) Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res 45: 5180–5185.

    PubMed  CAS  Google Scholar 

  • Wharton JT, Edwards CL, Rutledge FN (1984) Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma. Am J Obstet Gynecol 148: 997–1005.

    PubMed  CAS  Google Scholar 

  • Zinsser KR, Wheeler JE (1982) Endosalpingiosis in the omentum. A study of autopsy and surgical material. Am J Surg Pathol 6: 109–117.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. G. Silverberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Catedrático de Anatomia Patológica, Facultad de Medicina, Universidad de Granada, Avda. de Madrid s/n, 18012, Granada, Spain

    Francisco Nogales (Professor Dr.) (Professor Dr.)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Silverberg, S.G. (1989). Prognostic Significance of Pathologic Features of Ovarian Carcinoma. In: Nogales, F. (eds) Ovarian Pathology. Current Topics in Pathology, vol 78. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74011-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74011-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74013-8

  • Online ISBN: 978-3-642-74011-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation